Paradigm Biopharmaceuticals | PAR - Ebitda

Prix De L'Action
0.26
Variation Quotidienne
0 0%
Mensuellement
-19.05%
Annuel
-46.32%
Q1 Prévisions
0.25




Ebitda Changement Date
Avita Medical AUD -9.69M 12.21M 2025-12
Medical Developments International AUD 1.78M 3.78M 2024-12
Neuren Pharmaceuticals AUD 11.14M 165.56M 2025-12
Pacific Edge NZD -13.97M 332K 2024-09
PYC Therapeutics AUD -22.79M 1.5M 2025-12
Telix Pharmaceuticals AUD 18.42M 14.82M 2025-12